ST Pharm Co.,Ltd. (237690.KQ) KOE
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In KRW
| Market Cap | 2.45T |
| Enterprise Value | 2.5T |
| P/E Ratio | 25.9 |
| PEG Ratio | 0.43 |
| Price/Sales Ratio | 3.89 |
| Price/Book Ratio | 2.22 |
| Enterprise/Revenue | 3.95 |
| Enterprise/EBITDA | 16.37 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.15 |
| Operating Margin | 0.18 |
| Return On Assets | 0.07 |
| Return On Equity | 0.1 |
| Revenue | 331.55B |
| Revenue/Share | 21,583.6 |
| Gross Profit | 129.32B |
| EBITDA | 84.4B |
| Net Income | 54.99B |
| Diluted EPS | 2,688.35 |
| Total Cash | 183.41B |
| Total Cash/Share | 9,847.54 |
| Total Debt | 74.81B |
| Total Debt/Equity | 0.12 |
| Current Ratio | 2.28 |
| Book Value Per Share | 33,775.61 |
| 52-Week Change | -22.68 |
| 52-Week High | 172,100 |
| 52-Week Low | 68,900 |
| Moving Average 50 Days | 88,528 |
| Moving Average 200 Days | 122,634 |
| Average Volume | 139,054 |
| Shares Outstanding | 20.88M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 500 |
| Trailing Annual Dividend Yield | 0.67 |
| Payout Ratio | 0.17 |
| Last Split Factor | N/A |
| Last Split Date | N/A |